Pharmacogenetics of treatments for inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacogenetics of treatments for inflammatory bowel disease

Published:2018-12-02 Issue:12 Volume:14 Page:1209-1223
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Lucafò Marianna¹²,Franca Raffaella²³,Selvestrel Davide⁴,Curci Debora⁴,Pugnetti Letizia⁴,Decorti Giuliana²³,Stocco Gabriele⁵

Affiliation:

1. Experimental and Clinical Pharmacology Unit, National Cancer Institute – Centro di Riferimento Oncologico, Aviano, Italy

2. Institute for Maternal and Child Health IRCCS Burlo Garofolo, Diagnostics Department Trieste, Italy

3. Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy

4. PhD School in Science of Reproduction and Development, University of Trieste, Trieste, Italy

5. Department of Life Sciences, University of Trieste, Trieste, Italy

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2018.1551876

Reference146 articles.

1. Smoking and Inflammatory Bowel Disease: A Meta-analysis

2. Dietary Risk Factors for Inflammatory Bowel Disease

3. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

4. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

5. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin gene polymorphisms and alopecia areata: A systematic review and meta-analysis;Medicine;2024-02-23

2. Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease;Biomedicine & Pharmacotherapy;2023-08

3. One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study;The Pharmacogenomics Journal;2023-04-04

4. Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases;Therapeutic Drug Monitoring;2023-04-03

5. One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study;2023-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3